Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ARQT: Arcutis Biotherapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ARQT
The Story
ARQT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
+229.7% / yr
Operating margin
0.8%
ROIC
1.1%
Financially safe
Stretched
Debt / equity
0.60×
Interest coverage
0.2×
Current ratio
2.68×
Arcutis Biotherapeutics, Inc.
ARQT
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Arcutis Biotherapeutics, Inc.
ARQT
NASDAQ
·
USD
·
Closed
$26.86
−4.04%
$26.86
−$1.13 (4.04%)
52W Range
73th
pctl
Volume
0.81×
avg
Mkt Cap
3.36B
USD
P/E
-1399.0
TTM
Div Yield
–
ann
52W Range
73th
pctl
Volume
0.81×
avg
Market Cap
3.36B
USD
P/E Ratio
-1399.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings